Amneal Pharmaceuticals, Inc. (AMRX): Price and Financial Metrics


Amneal Pharmaceuticals, Inc. (AMRX)

Today's Latest Price: $4.05 USD

0.10 (2.53%)

Updated Dec 1 7:00pm

Add AMRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AMRX Stock Summary

  • Amneal Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.33% of US listed stocks.
  • Amneal Pharmaceuticals Inc's stock had its IPO on March 27, 2018, making it an older stock than only 7.83% of US equities in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 13.95 for Amneal Pharmaceuticals Inc; that's greater than it is for 96.4% of US stocks.
  • Stocks that are quantitatively similar to AMRX, based on their financial statements, market capitalization, and price volatility, are ALSN, ITGR, CAE, ENVA, and CC.
  • AMRX's SEC filings can be seen here. And to visit Amneal Pharmaceuticals Inc's official web site, go to www.amneal.com.

AMRX Stock Price Chart Interactive Chart >

Price chart for AMRX

AMRX Price/Volume Stats

Current price $4.05 52-week high $5.79
Prev. close $3.95 52-week low $2.40
Day low $3.91 Volume 1,609,299
Day high $4.09 Avg. volume 1,550,208
50-day MA $4.39 Dividend yield N/A
200-day MA $4.17 Market Cap 1.21B

Amneal Pharmaceuticals, Inc. (AMRX) Company Bio


Amneal Pharmaceuticals (formerly Impax Laboratories) develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. The company was founded in 1993 and is based in Hayward, California.

AMRX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$4.05$35.4 761%

We started the process of determining a valid price forecast for Amneal Pharmaceuticals Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Amneal Pharmaceuticals Inc ranked in the 83th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for AMRX, they are:

  • 17% of the company's capital comes from equity, which is greater than merely 5.7% of stocks in our cash flow based forecasting set.
  • Amneal Pharmaceuticals Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • Relative to other stocks in its sector (Healthcare), Amneal Pharmaceuticals Inc has a reliance on debt greater than 95.79% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%744%
1%753%
2%761%
3%770%
4%778%
5%787%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMRX, try PRSC, GTS, ARGX, HCA, and NHC.


AMRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRX Latest Social Stream


Loading social stream, please wait...

View Full AMRX Social Stream

Latest AMRX News From Around the Web

Below are the latest news stories about Amneal Pharmaceuticals Inc that investors may wish to consider to help them evaluate AMRX as an investment opportunity.

Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Amneal Pharmaceuticals (AMRX) Gains As Market Dips: What You Should Know

In the latest trading session, Amneal Pharmaceuticals (AMRX) closed at $4.46, marking a +0.45% move from the previous day.

Yahoo | July 23, 2020

Can Amneal (AMRX) Keep the Earnings Surprise Streak Alive?

Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 22, 2020

Amneal Pharmaceuticals (AMRX) Gains But Lags Market: What You Should Know

Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.86, moving +0.21% from the previous trading session.

Yahoo | July 17, 2020

Could The Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Ownership Structure Tell Us Something Useful?

The big shareholder groups in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) have power over the company. Insiders often own...

Yahoo | July 16, 2020

Read More 'AMRX' Stories Here

AMRX Price Returns

1-mo -9.40%
3-mo 8.58%
6-mo -18.18%
1-year 0.25%
3-year -75.82%
5-year -90.84%
YTD -15.98%
2019 -64.38%
2018 -18.74%
2017 25.66%
2016 -69.01%
2015 34.97%

Continue Researching AMRX

Here are a few links from around the web to help you further your research on Amneal Pharmaceuticals Inc's stock as an investment opportunity:

Amneal Pharmaceuticals Inc (AMRX) Stock Price | Nasdaq
Amneal Pharmaceuticals Inc (AMRX) Stock Quote, History and News - Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0019 seconds.